BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 1998
View Archived Issues
The role of Ca2+-activated K+ channels in bronchorelaxation by NKH-477
Read More
Nabi: Q4 and year-end 1997 highlights
Read More
Cantab: year-end 1997 highlights
Read More
MRX-115 allows for accurate assessment of AMI in dogs
Read More
NeuroSearch: year-end 1997 highlights
Read More
Inhibitors of selectin binding and cell adhesion prepared at Nippon Shinyaku
Read More
Zadaxin shows wound-healing properties
Read More
Nikken Chemicals develops new agents for asthma
Read More
Improved agents for schizophrenia developed at Yoshitomi
Read More
SangStat and Dyax enter license agreement
Read More
p24-VLP safe but not immunogenic in phase II trials
Read More
Depsipeptides useful in dementia under evaluation at Nisshin Flour Milling
Read More
Cardiovascular disease gene discovered
Read More
Third phase II trial begins of ONYX-015 in head and neck cancer
Read More
Company Profile: Angiotech
Read More
Fortovase cited as preferred therapy in AIDS guidelines
Read More
Aricept launched in France
Read More
Aquila Biopharmaceuticals: Q4 and year-end 1997 highlights
Read More
Glaxo Wellcome researches MMP inhibitors
Read More
Neuroprotective glutamate antagonists from Warner-Lambert
Read More
Novartis describes new thrombin inhibitors
Read More
Enbrel safety established in juvenile RA patients; efficacy data now being generated
Read More
Zenapax launched in Switzerland
Read More
Lidakol NDA accepted for review
Read More
Phase II trial begins with rPAF-AH in pancreatitis
Read More
Abbott announces intention to acquire Murex
Read More
AIDS patients will have expanded access to Ziagen
Read More
Isis reports incident of data manipulation; clinical progress will not be affected
Read More
Nuvance stabilizes lung function in asthmatic patients
Read More
Spherons: a time bomb in the human brain?
Read More
Merck & Co. obtains improved analogues of montelukast
Read More
